ACLX20250516C115
ACLX May 16 2025 115.00 Call (ACLX250516C00115000)
option OPRA

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.